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Positive answer to two out of three: 1) Doctors diagnosed asthma ever (parental reported); 2) Asthma medication in the past 12 months (parental reported); 3) Wheezing in the past 12 months (parental reported).
Positive answer to two out of three: 1) Doctors diagnosed asthma ever (parental reported); 2) Asthma medication in the past 12 months (child reported, if available); 3) Wheezing in the past 12 months and/or breathing difficulties, where available (child reported, if available).
Rhinoconjunctivitis
Positive answer to the following questions: 1) In the past 12 months problems with sneezing, or a runny, or blocked nose when child did not have a cold or flu (parental reported); 2) In the past 12 months, has this nose problem been accompanies by itchy-watery eyes (parental reported).
Positive answer to the following questions: 1) In the past 12 months problems with sneezing, or a runny, or blocked nose when child did not have a cold or flu (child reported, if available); 2) In the past 12 months, has this nose problem been accompanies by itchy-watery eyes (child reported, if available). 
X indicates all follow-ups conducted in each cohort. X indicates outcome interval used. X c indicates where children reported symptoms were utilized. N = total number of exposed children and n = number of exposed cases. b ORs and 95% CIs obtained from multinomial logistic regression analyses adjusted for sex, parental education level, parental allergy, older siblings, breastfeeding, study center, intervention arm, and early day-care attendance. ORs and 95% CIs obtained from GEE analyses adjusted for sex, parental education level, older siblings, breastfeeding, study center, intervention arm, and early day-care attendance. ORs and 95% CIs obtained from GEE analyses adjusted for parental education level, parental allergy, older siblings, breastfeeding, study center, intervention arm, and early day-care attendance. Figure S4 . Association between maternal smoking during pregnancy and asthma only, rhinoconjunctivitis only, or concurrent asthma and rhinoconjunctivitis up to 14 to 16 years of age in five European birth cohorts. Cohort specific odds ratios (OR) and 95% confidence intervals (CI) were obtained by GEE models adjusted for sex, parental education level, parental allergy, older siblings, breastfeeding, study center, intervention arm, and early day-care attendance. Combined OR and 95% CI were derived from cohort-specific OR and 95% CI using a random effects model. 
